American Journal of Kidney Diseases
Volume 49, Issue 6 , Pages 763-775 , June 2007

A Novel Simpler Histological Classification for Renal Survival in IgA Nephropathy: A Retrospective Study

Received 9 October 2006 ,Accepted 19 March 2007.

References 

  1. D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;245:709–727
  2. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide: A neglected disease in the United States?. Am J Med. 1988;84:129–132
  3. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med. 1990;89:209–215
  4. Coppo R, Amore A, Hogg R, Emancipator S. Idiopathic nephropathy with IgA deposits. Pediatr Nephrol. 2000;15:139–150
  5. Schena FP Italian Group of Renal Immunopathology. Survey of the Italian Registry of renal biopsies: Frequency of renal diseases for 7 consecutive years. Nephrol Dial Transplant. 1997;12:418–426
  6. Espanol de Glomerulonefritis. Evolucion de la frecuencia de las glomerulonefritis primarias y secundarias en Espana en los anos 1991 y 1992. Nefrologia. 1994;14:228–296
  7. Smith SM, Tung KS. Incidence of IgA-related nephritides in American Indians in New Mexico. Hum Pathol. 1985;16:181–184
  8. Central Committee of the Toronto Glomerulonephritis Registry. Regional program for the study of glomerulonephritis. Can Med J. 1981;124:158–161
  9. Research Group on Progressive Chronic Renal Disease. Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1850 biopsied cases. Nephron. 1999;82:205–213
  10. Manno C, Giancaspro V, Schena FP e Gruppo di Immunopatologia Renale della Societa’ Italiana di Nefrologia. Rapporto finale sul Registro Italiano delle Biopsie Renali (anni 1987-1995). Giorn It Nefrol. 1998;15:281–290
  11. Gesualdo L, Di Palma AM, Morrone LF, Strippoli GF, Schena FP Italian Immunopathology Group, Italian Society of Nephrology. The Italian experience of the national registry of renal biopsies. Kidney Int. 2004;66:890–894
  12. Wyatt RS, Julian BA, Bachler RW, et al. Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994. J Am Soc Nephrol. 1998;9:853–858
  13. Simon P, Ramée MP, Autuly V, et al. Epidemiology of primary glomerular disease in a French region (Variations according to period and age). Kidney Int. 1994;46:1192–1198
  14. Berger J, Hinglais N. Les dèpots intracapillaires d’IgA-IgG. J Urol Nèphrol. 1968;74:694–695
  15. Lee S-MK, Rao VM, Franklin WA, et al. IgA nephropathy: Morphologic predictors of progressive renal disease. Hum Pathol. 1982;13:314–322
  16. Haas M. Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829–842
  17. Schena FP, Coppo R. IgA nephropathies. In:  Davison AM,  Cameron JS,  Grunfeld JP, et al. editor. Oxford Textbook of Clinical Nephrology. (ed 3). New York, NY: Oxford University; 2004;p. 470–501
  18. Churg J, Bernstein J, Glassock R. Glomerular Diseases. (ed 2). Tokyo, Japan: Igaku-Shoin; 1995;
  19. Lebacqz K, Levine RJ. Respect for persons and informed consent to participate in research. Clin Res. 1977;25:101–107
  20. Nicholls KM, Fairley KF, Dowling JP, Kincaid-Smith P. The clinical course of mesangial IgA associated nephropathy in adults. Q J Med. 1984;53:22–50
  21. D’Amico G, Minetti L, Ponticelli G, et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med. 1986;59:363–378
  22. Beukhof JR, Kardaun O, Schaafsma W, et al. Toward individual prognosis of IgA nephropathy. Kidney Int. 1986;29:549–556
  23. Woo KT, Edmondson RPS, Wu AYT, et al. The natural history of IgA nephritis in Singapore. Clin Nephrol. 1986;25:15–21
  24. Kusumoto Y, Takebayashi S, Taguchi T, et al. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and adult Japanese. Clin Nephrol. 1987;28:118–124
  25. Noel LH, Droz D, Gascon M, Berger J. Primary IgA nephropathy: From the first-described cases to the present. Semin Nephrol. 1987;7:351–354
  26. Velo M, Lozano L, Egido J, et al. Natural history of IgA nephropathy in patients followed up for more than ten years in Spain. Semin Nephrol. 1987;7:346–350
  27. Bogenschutz O, Bohle A, Batz C, et al. IgA nephritis: On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol. 1990;10:137–147
  28. Rekola S, Bergstrand A, Buch H. IgA nephropathy (Development of hypertension in IgA nephropathy as a marker of poor prognosis). Am J Nephrol. 1990;10:290–295
  29. Alamartine E, Sabatier JC, Guerin C, et al. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am J Kidney Dis. 1991;18:12–19
  30. Johnston PA, Brown JS, Braumholtz DA, Davison AM. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy (A report from the MRC Glomerulonephritis Registry). Q J Med. 1992;304:619–627
  31. Ibels LS, Györy AZ. IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine. 1994;73:79–102
  32. Katafuchi R, Oh Y, Hori K, et al. An important role of glomerular segmental lesions on progression of IgA nephropathy: A multivariate analysis. Clin Nephrol. 1994;41:191–198
  33. Yagame M, Suzuki D, Jinde K, et al. Value of pathological grading in prediction of renal survival in IgA nephropathy. Nephrology. 1996;2:107–117
  34. Koyama A, Igarashi M, Kobayashi M Members and Coworkers of the Research Group on Progressive Renal Disease. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis. 1997;29:526–532
  35. D’Altri C, Manno C, Rossini M, et al. Studio clinico-patologico retrospettivo in 543 pazienti affetti da nefropatia IgA. G Ital Nefrol. 2001;4:425–432
  36. Li PK, Ho KK, Szeto CC, et al. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant. 2002;17:64–69
  37. Radford MG, Donadio JV, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997;8:199–207
  38. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting IgA nephropathy. Am J Kidney Dis. 2001;38:728–735
  39. Wyatt RJ, Julian BA, Bathena DB, et al. IgA nephropathy: Presentation, clinical course, and prognosis in children and adults. Am J Kidney Dis. 1984;4:192–200
  40. D‘Amico G. Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis. 2000;36:227–237
  41. D’Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004;24:179–196
  42. Wyatt RJ, Emancipator SN, Kon V, et al. IgA nephropathy databank: Development of a system for management of renal biopsy acquired data. Am J Kidney Dis. 1997;29:817–828
  43. Mina SN, Murphy WM. A comparative study of the clinicopathologic features in children and adults. Am J Clin Pathol. 1985;83:669–675
  44. Kobayashi Y, Tateno S, Shigematsu H. IgA nephropathy: Prognostic significance of proteinuria and histological alterations. Nephron. 1983;34:146–153
  45. Andreoli SP, Bergstein JM. Treatment of severe IgA nephropathy in children. Pediatr Nephrol. 1989;3:248–253
  46. Waldo FB, Wyatt RJ, Kelly DR, Herrera GA, Benefield MR, Kohaut EC. Treatment of IgA nephropathy in children: Efficacy of alternate-day oral prednisone. Pediatr Nephrol. 1993;7:529–532
  47. D’Amico G, Ragni A, Gandini E, Fellin G. Typical and atypical natural history of IgA nephropathy in adult patients. Contrib Nephrol. 1993;104:6–13
  48. Samuels JA, Strippoli G, Craig JC, Schena FP, Molony DA. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database Syst Rev CD003965. 2003;
  49. Strippoli G, Manno C, Schena FP. An evidence-based survey of therapeutic options for IgA nephropathy: Assessment and criticism. Am J Kidney Dis. 2003;41:1129–1139

 Support: This study was partially supported by grants from the 5th European Framework Programme (QLG1-CT-2000-00464), Ministero dell’Università e Ricerca (PRIN 2001-067748 and FIRB 2001-RBNEO13JYM), and Ministero della Salute (RC2006). Potential conflicts of interest: None.

 Originally published online as doi:10.1053/j.ajkd.2007.03.013 on May 3, 2007.

PII: S0272-6386(07)00645-2

doi: 10.1053/j.ajkd.2007.03.013

American Journal of Kidney Diseases
Volume 49, Issue 6 , Pages 763-775 , June 2007

Article Tools

* Image Usage & Resolution